NOVARA THERAPEUTICS LIMITED

Active London

Other professional, scientific and technical activities n.e.c.

0 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
N

NOVARA THERAPEUTICS LIMITED

Other professional, scientific and technical activities n.e.c.

Founded 27 Aug 2020 Active London, United Kingdom 0 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
Accounts Submitted 7 Nov 2024 Next due 31 Dec 2025 6 months overdue
Confirmation Submitted 6 Sept 2024 Next due 9 Sept 2025 9 months overdue
Net assets £-29K £2K 2023 year on year
Total assets £198 £0 2023 year on year
Total Liabilities £29K £2K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Furlong House 10a Chandos Street London W1G 9DQ United Kingdom

Website

www.example.com

Full company profile for NOVARA THERAPEUTICS LIMITED (12841228), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 27 Aug 2020. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2024
Type total-exemption-full
Next accounts 31 Mar 2025
Due by 31 Dec 2025 6 months overdue

Net Assets, Total Assets & Total Liabilities (2020–2023)

Cash in Bank

N/A

Net Assets

-£28.82k

Decreased by £1.88k (-7%)

Total Liabilities

£29.02k

Increased by £1.88k (+7%)

Turnover

N/A

Employees

N/A

Debt Ratio

14655%

Increased by 952 (+7%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Mar Year End
2023
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active
Status
Arash MoavenianDirectorBritishUnited Kingdom3927 Aug 2020Active
Martin John GouldstoneDirectorBritishUnited Kingdom5927 Aug 2020Active

Shareholders

Shareholders (2)

Orthopaedic Research Uk
85.0%
Embryo Ventures Ltd
15.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 27 Aug 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

NOVARA THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Oct 2025GazetteGazette Dissolved Voluntary
22 Jul 2025GazetteGazette Notice Voluntary
14 Jul 2025DissolutionDissolution Application Strike Off Company
7 Nov 2024AccountsAnnual accounts made up to 31 Mar 2024
6 Sept 2024Confirmation StatementConfirmation statement made on 26 Aug 2024 with no updates
7 Oct 2025 Gazette

Gazette Dissolved Voluntary

22 Jul 2025 Gazette

Gazette Notice Voluntary

14 Jul 2025 Dissolution

Dissolution Application Strike Off Company

7 Nov 2024 Accounts

Annual accounts made up to 31 Mar 2024

6 Sept 2024 Confirmation Statement

Confirmation statement made on 26 Aug 2024 with no updates

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

7 months ago on 7 Oct 2025

Gazette Notice Voluntary

10 months ago on 22 Jul 2025

Dissolution Application Strike Off Company

10 months ago on 14 Jul 2025

Annual accounts made up to 31 Mar 2024

1 years ago on 7 Nov 2024

Confirmation statement made on 26 Aug 2024 with no updates

1 years ago on 6 Sept 2024